Schering-Plough - PDFSEARCH.IO - Document Search Engine

Schering-Plough
Results: 410

#	Item
211	DEPARTMENT OF H & HUMAN SERVICES Add to Reading List Source URL: www.fda.gov Language: English - Date: 2003-12-22 17:39:34 Term of patent in the United States United States patent law Schering-Plough Food and Drug Administration Term of patent Pharmacology Patent law Pharmaceutical sciences Clinical research
212	Re: GlobalRegulatory Policy October25, 2004 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-11-12 10:46:15 Clinical research Food and Drug Administration Dow Jones Industrial Average Merck & Co. Readington New Jersey Schering-Plough Center for Biologics Evaluation and Research Biologic Biotechnology Pharmacology Pharmaceutical sciences
213	RE: DavidW. Blois. Ph.D. SeniorVice President GlobalRegulatoryPolicy Add to Reading List Source URL: www.fda.gov Language: English - Date: 2003-12-24 15:14:48 Business Pharmaceutical sciences Pharmacology Clinical research Schering-Plough Pharmaceutical marketing Merck & Co. Food and Drug Administration Advertising Direct-to-consumer advertising Marketing
214	New Jersey Department of Agriculture Memo To: Veterinarians Add to Reading List Source URL: www.esc.rutgers.edu Language: English - Date: 2010-05-04 14:45:32 Vaccines Vaccination Merck Schering-Plough West Nile virus Medicine Biology Health
215	KAYE SCHOLER LLP Randolph S. Sherman Direct Dial: [removed] Add to Reading List Source URL: www.fda.gov Language: English - Date: 2001-12-06 10:20:47 Kaye Scholer Schering-Plough Food and Drug Administration Phenylpropanolamine Pharmacology Pharmaceutical sciences Medicine
216	----------------------DOSAGE FORMS AND STRENGTHS--------------------• 50 mg/10 mL (5 mg/mL) (3) • 200 mg/40 mL (5 mg/mL[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-03-28 12:08:27 Centocor Infliximab Schering-Plough Corticosteroid Autoimmune diseases Adverse effect Anakinra Management of ulcerative colitis Medicine Immunosuppressants Health
217	PDF Document Add to Reading List Source URL: www.fda.gov Language: English - Date: 2001-10-29 11:24:25 Food and Drug Administration Clinical pharmacology Therapeutics United States Public Health Service Phenylpropanolamine Schering-Plough Pharmaceutical industry Compounding New Drug Application Pharmaceutical sciences Pharmacology Medicine
218	Documentation of Environmental Indicator Determination - Schering Corporation, Union, New Jersey Add to Reading List Source URL: www.epa.gov Language: English - Date: 2008-06-12 17:00:37 Soil contamination Aquifers Environmental chemistry Hydrogeology Benzene Soil Schering-Plough Groundwater Volatile organic compound Environment Chemistry Pollution
219	DEPAKUHENT OF HEALTH mMAN Public HealthServka Add to Reading List Source URL: www.fda.gov Language: English - Date: 2001-03-15 10:05:00 Pharmacology Piperazines Piperidines Schering-Plough Johnson & Johnson Loratadine Cetirizine Pseudoephedrine/loratadine Food and Drug Administration Chemistry Organic chemistry Organochlorides
220	Bonnie J. Goldmann,M.D Vice President RegulatoryAffairs Merck & Co.,Inc. West Point PA 19486 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2001-02-08 10:28:46 Research Dow Jones Industrial Average Merck & Co. Readington New Jersey Schering-Plough Medical prescription Survey methodology Science Statistics Pharmacology

UPDATE